Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Store
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Heatmap
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
TARS
#1663
Tarsus Pharmaceuticals, Inc. Common Stock
72.840
0
USD
+0.26%
Sektör:
Sağlık Hizmetleri
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
+0.26%
Aylık Değişim
+6.32%
6 aylık değişim
+10.26%
Yıllık Değişim
+10.26%
Önceki Kapanış
72.650
0
Open
72.720
0
Bid
Ask
Low
72.570
0
High
72.950
0
Hacim
79
Piyasalar
ABD Borsası
Sağlık Hizmetleri
TARS
Open full chart
Financials
Overview
Rapor
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
20.5 M
20.71 M
26.73 M
34.22 M
38.38 M
42.56 M
—
Valuation ratios
Enterprise value
679.26 M
294.62 M
334.13 M
496.64 M
2.1 B
3.38 B
9.62 B
Price to earnings ratio
—
-33.58
-5.72
-4.36
-18.04
-51.5
-118
Price to sales ratio
—
8.11
13.75
33.95
11.38
7.58
28.09
Price to cash flow ratio
—
123.39
-7.24
-5.04
-25.08
-274.78
-367.61
Price to book ratio
—
2.77
1.84
3.01
9.27
9.96
15.19
Enterprise value to EBITDA ratio
-25.34
-25.52
-4.97
-3.2
-16.5
-44.58
-104.72
Profitability ratios
Return on assets %
-0.16
-0.08
-0.27
-0.51
-0.31
-0.12
-0.13
Return on equity %
-0.16
-0.08
-0.32
-0.69
-0.51
-0.19
-0.2
Return on invested capital %
-1 906.71
-566.25
-2 112.36
-2 838.11
-1 840.82
-617.61
—
Gross margin %
—
100
100
100
100
100
400
Operating margin %
—
-21.32
-242.92
-820.53
-65.9
-15.72
-72.66
EBITDA margin %
—
-20.24
-244.4
-831.43
-67.27
-16.4
-75.25
Net margin %
—
-24.25
-240.51
-778.89
-63.16
-14.72
-68
Liquidity ratios
Quick ratio
—
—
—
6.85
4.39
3.82
18.83
Current ratio
31.68
15.33
14.61
6.93
4.42
3.85
18.97
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0
0.33
0.13
0.07
0.57
0.96
0.89
Solvency ratios
Debt to assets ratio
—
—
0.09
0.12
0.19
0.15
0.59
Debt to equity ratio
—
—
0.11
0.16
0.32
0.24
0.92
Long term debt to total assets ratio
—
—
0.09
0.11
0.19
0.13
0.55
Long term debt to total equity ratio
—
—
0.1
0.15
0.32
0.21
0.85
Per share metrics
Operating cash flow per share
—
0.18
-1.99
-4
-2.21
-0.3
-0.33
EBIT per share
—
-0.59
-2.55
-4.87
-3.21
-1.7
-1.72
EBITDA per share
—
-0.56
-2.56
-4.94
-3.27
-1.77
-1.78
Total debt per share
—
—
0.83
1.08
1.93
1.99
7.47
Cash per share
—
8.36
8.82
7.74
7.75
9.99
38.78
Net current asset value per share
—
8.56
9.15
8.72
9.49
12.51
47.71
Tangible book value per share
—
8.11
7.84
6.57
5.75
8.04
31.89
Working capital per share
—
8
8.53
7.46
7.34
9.26
37.39
Book value per share
—
8.11
7.84
6.7
5.97
8.22
32.64
Haberler
Tarsus Pharmaceuticals: Marketing Spend Bears Fruit, Pipeline Progresses (NASDAQ:TARS)
Gold Stocks, AI Leader Broadcom Among 25 Newcomers To Best Stock Lists
Tarsus, Lyme hastalığı önleme denemesinde ilk hastayı tedavi etti
Tarsus Pharmaceuticals Stock Earns Upgrade To RS Rating
Mizuho, Çin onayı sonrası Tarsus hisse hedefini yükseltti
William Blair, Tarsus Pharmaceuticals hissesi için Outperform tavsiyesini korudu
Tarsus Pharmaceuticals hisseleri Çin ilaç onayıyla yükseldi
Tarsus, Çin’deki göz ilacı onayıyla 15 milyon dolar kazandı
Cloudflare Qualifies For Two Top Stock Lists, Leads 13 Newcomers To IBD 50, Stock Spotlight, More
Tarsus Pharmaceuticals Barclays Konferansı: Büyüme ve Zorluklar
Tarsus Pharmaceuticals at Barclays Conference: Strategic Growth and Challenges
Tarsus Pharma COO’su 641 bin dolarlık hisse sattı